Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Susceptibility to respiratory infections associated with CD8 alpha chain mutation is a rare primary immunodeficiency due to a defect in adaptive immunity characterized by the absence of CD8+ T cells with normal immunoglobulin and specific antibody titres in blood and susceptibility to recurrent respiratory bacterial and viral infections. Symptom severity range from fatal respiratory insufficiency to mild or asymptomatic phenotypes.
Features include: Absence of CD8-positive T cells, Bronchiectasis, Recurrent bacterial infections, and Recurrent viral infections and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 3 | Recurrent bacterial infections, Recurrent viral infections, Recurrent respiratory infections |
CD8A encodes CD8 subunit alpha (235 aa). Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. Highest expression in Spleen (103.4 TPM) and Whole Blood (20.4 TPM).
Susceptibility to respiratory infections associated with CD8alpha chain mutation has limited evidence linking it to mutations in the CD8A gene on chromosome 2.
CD8A is classified as a druggable target (Druggable Genome, External Side Of Plasma Membrane, and Kinase categories) with score 26.1.
Genetic testing for CD8A is available. Testing is considered research-grade for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for susceptibility to respiratory infections associated with CD8alpha chain mutation.
2 publications have been identified in PubMed for susceptibility to respiratory infections associated with CD8alpha chain mutation. Research spans Case Report / Case Series (50%) and Gene Therapy / Novel Therapeutics (50%).
Ahn JJ (2025). [PMID: 40744022](https://pubmed.ncbi.nlm.nih.gov/40744022/). *Cell reports. Medicine*. [Gene Therapy / Novel Therapeutics]
Guérin A (2024). [PMID: 38557723](https://pubmed.ncbi.nlm.nih.gov/38557723/). *The Journal of experimental medicine*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 8:45 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Lungs and breathing
2 |
Bronchiectasis, Recurrent respiratory infections |